In addition to the trade-off described by Kulminski et al. with APOE4 postponing cancers to older ages11, other studies have also reported that APOE4 carriers have lowered mortality risk for some common cancers including melanoma19, colon cancer20, and colorectal neoplasm21. Here, APOE is linked to cancer.